Target Discovery

News

AI in drug discovery and development: news watch

Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.

News

MSD taps Quotient for IBD drug targets in $2.2bn deal

MSD is paying $20m upfront to activate an alliance with Flagship's Quotient Therapeutics to find new targets in inflammatory bowel disease.

News

JPM: Illumina launches 'unprecedented' disease biology atlas

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

News

Lab-in-a-loop specialist Relation attracts Novartis alliance

UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.

News

AstraZeneca joins Tempus, Pathos in cancer AI project

AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology.

News

CRUK scientists find new tool to test lung cancer therapies

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.

AI in drug discovery and development: news watch

MSD taps Quotient for IBD drug targets in $2.2bn deal

JPM: Illumina launches 'unprecedented' disease biology atlas

Lab-in-a-loop specialist Relation attracts Novartis alliance

AstraZeneca joins Tempus, Pathos in cancer AI project

CRUK scientists find new tool to test lung cancer therapies

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

Target Discovery

Editor's Picks